{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:42:40Z","timestamp":1771047760473,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jogc.2016.12.006","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T06:39:05Z","timestamp":1493188745000},"page":"366-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["No. 343-Routine Non-invasive Prenatal Prediction of Fetal RHD Genotype in Canada: The Time is Here"],"prefix":"10.1016","volume":"39","author":[{"given":"Jo-Ann","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Skoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2016.12.006_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0887-7963(88)70039-5","article-title":"The prevention of Rh immunization","volume":"2","author":"Bowman","year":"1988","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jogc.2016.12.006_bib2","first-page":"600","article-title":"Management of rhesus alloimmunization in pregnancy","volume":"100","author":"Moise","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.006_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/bmj.330.7502.1255","article-title":"Management of pregnancies with RhD alloimmunisation","volume":"330","author":"Kumar","year":"2005","journal-title":"BMJ"},{"issue":"Suppl 18","key":"10.1016\/j.jogc.2016.12.006_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","article-title":"The scientific basis of antenatal prophylaxis","volume":"105","author":"Urbaniak","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2016.12.006_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9378(85)90288-1","article-title":"Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?","volume":"151","author":"Bowman","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.006_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1471-0528.1994.tb13613.x","article-title":"Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990","volume":"101","author":"Hughes","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2016.12.006_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1423-0410.1986.tb00226.x","article-title":"Fetomaternal transplacental hemorrhage during pregnancy and after delivery","volume":"51","author":"Bowman","year":"1986","journal-title":"Vox Sang"},{"key":"10.1016\/j.jogc.2016.12.006_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-3148.1999.009001093.x","article-title":"Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists","volume":"9","author":"Lee","year":"1999","journal-title":"Transfus Med"},{"key":"10.1016\/j.jogc.2016.12.006_bib9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/aogs.12193","article-title":"Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies","volume":"92","author":"Tiblad","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2016.12.006_bib10","first-page":"CD000020","article-title":"Anti-D administration in pregnancy for preventing rhesus alloimmunisation","author":"Crowther","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2016.12.006_bib11","doi-asserted-by":"crossref","DOI":"10.3310\/hta7040","article-title":"A\u00a0review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative","volume":"7","author":"Chilcott","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jogc.2016.12.006_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0895-4356(90)90073-X","article-title":"Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination","volume":"43","author":"Woolf","year":"1990","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jogc.2016.12.006_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1701-2163(16)31006-4","article-title":"Prevention of Rh alloimmunization","volume":"25","author":"Fung Kee Fung K","year":"2003","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.12.006_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.siny.2007.12.012","article-title":"Non-invasive prenatal diagnosis and determination of fetal Rh status","volume":"13","author":"van der Schoot","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2016.12.006_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2016.12.006_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000322959","article-title":"Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation","volume":"29","author":"Akolekar","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2016.12.006_bib17","doi-asserted-by":"crossref","first-page":"g5243","DOI":"10.1136\/bmj.g5243","article-title":"Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study","volume":"349","author":"Chitty","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2016.12.006_bib18","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/1471-0528.13055","article-title":"Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS","volume":"122","author":"Soothill","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2016.12.006_bib19","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1537-2995.2011.03362.x","article-title":"Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis","volume":"52","author":"Clausen","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2016.12.006_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","article-title":"Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study","volume":"336","author":"Finning","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2016.12.006_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000356078","article-title":"Noninvasive fetal RhD status determination in early pregnancy","volume":"35","author":"Manzanares","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2016.12.006_bib22","first-page":"411","article-title":"A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA","volume":"25","author":"Tounta","year":"2011","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.jogc.2016.12.006_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1537-2995.2002.00165.x","article-title":"Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service","volume":"42","author":"Finning","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2016.12.006_bib24","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1537-2995.2007.01437.x","article-title":"Fetal genotyping for the K\u00a0(Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma","volume":"47","author":"Finning","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2016.12.006_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2393-14-87","article-title":"Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice","volume":"14","author":"Kent","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2016.12.006_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1755-618X.2011.01269.x","article-title":"Blood donation and institutional trust: risk, policy rhetoric, and the men who have sex with men lifetime deferral policy in Canada","volume":"48","author":"Smith","year":"2011","journal-title":"Can Rev Sociol"},{"key":"10.1016\/j.jogc.2016.12.006_bib27","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2016.12.006_bib28","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","article-title":"Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis","volume":"62","author":"Lo","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jogc.2016.12.006_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejogrb.2014.08.028","article-title":"The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis","volume":"182","author":"Beulen","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2016.12.006_bib30","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1182\/blood.V78.10.2747.2747","article-title":"Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis","volume":"78","author":"Colin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jogc.2016.12.006_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/bjh.12275","article-title":"Variants of RhD\u2013current testing and clinical consequences","volume":"161","author":"Daniels","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jogc.2016.12.006_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pd.2172","article-title":"Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects","volume":"29","author":"Daniels","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2016.12.006_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/tmrv.2003.50001","article-title":"Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed","volume":"17","author":"van der Schoot","year":"2003","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jogc.2016.12.006_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0b013e31825d33d9","article-title":"Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy","volume":"120","author":"Wikman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.006_bib35","first-page":"160","article-title":"Noninvasive prenatal screening for RHD: the 1st national antenatal directed anti-D prophylaxis program - the Danish Model or a guide to robost prediction of need of Anti-D","author":"Dziegala","year":"2012","journal-title":"Sci Ser"},{"key":"10.1016\/j.jogc.2016.12.006_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1751-2824.2012.01600.x","article-title":"A\u00a0nation-wide fetal RHD screening programme for targeted antenatal and postnatal anti-D","volume":"7","author":"de Haas","year":"2012","journal-title":"ISBT Science Series"},{"key":"10.1016\/j.jogc.2016.12.006_bib37","doi-asserted-by":"crossref","first-page":"e70984","DOI":"10.1371\/journal.pone.0070984","article-title":"Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation\u2013outcome of a new antenatal screening and prevention program","volume":"8","author":"Tiblad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2016.12.006_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1537-2995.2007.01533.x","article-title":"Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium","volume":"48","author":"Minon","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.jogc.2016.12.006_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/pd.4326","article-title":"Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care","volume":"34","author":"Clausen","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2016.12.006_bib40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1471-0528.2006.00988.x","article-title":"Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years","volume":"113","author":"MacKenzie","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2016.12.006_bib41","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta13100","article-title":"Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation","volume":"13","author":"Pilgrim","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jogc.2016.12.006_bib42","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1701-2163(16)35239-2","article-title":"Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?","volume":"34","author":"Koby","year":"2012","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.12.006_bib43","series-title":"Detection and prevention of pregnancy immunisation: The OPZI-study","author":"Koelewijn","year":"2009"},{"key":"10.1016\/j.jogc.2016.12.006_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1423-0410.2007.00945.x","article-title":"Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers","volume":"93","author":"Kumpel","year":"2007","journal-title":"Vox Sang"},{"key":"10.1016\/j.jogc.2016.12.006_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/AOG.0b013e31829f8814","article-title":"Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis","volume":"122","author":"Hawk","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.006_bib46","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1701-2163(15)30864-1","article-title":"Cost-effectiveness of the management of rh-negative pregnant women","volume":"35","author":"Duplantie","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2016.12.006_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejogrb.2012.02.001","article-title":"Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study","volume":"162","author":"Benachi","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2016.12.006_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2393-11-5","article-title":"A\u00a0new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales","volume":"11","author":"Szczepura","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2016.12.006_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/uog.14723","article-title":"Costs and benefits of non-invasive fetal RhD determination","volume":"45","author":"Teitelbaum","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2016.12.006_bib50","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/1471-0528.13801","article-title":"Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis","volume":"123","author":"Neovius","year":"2016","journal-title":"BJOG"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316399042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216316399042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:29:15Z","timestamp":1761665355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216316399042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1701216316399042"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2016.12.006","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No. 343-Routine Non-invasive Prenatal Prediction of Fetal RHD Genotype in Canada: The Time is Here","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}